AIkido Pharma receives unsolicited $8.00/share acquisition proposal, board rejects it

Dominari Holdings Inc.

Shalom Auerbach proposed to acquire all outstanding shares for $8.00 per share in cash.
Board reviewed the offer and sent a letter on August 18, 2022, declining the proposal.
No reasons for rejection or further details were disclosed in the filing.

item 8.01

Dominari Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-049761

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.